Medical Device News Magazine

Owen Mumford Publishes Annual Responsible Action Report

Highlighting B Corp Certification and Science-Based Targets Milestones

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Owen Mumford (medical device manufactuer) has published its latest annual Responsible Action Report, highlighting progress and achievements in 2021 including its recent B Corp certification and alignment with the Science Based Targets initiative (SBTi) to achieve net zero carbon emissions by 2045, as the company continues to strengthen its sustainability strategy and future-proof its operations.

In June 2021, Owen Mumford was awarded B Corp certification in recognition of its commitment to corporate social responsibility regarding the environment, governance, community engagement, employee support, and customer stewardship. The certification makes Owen Mumford one of the first medical device manufacturers in the world to achieve this, joining over 4,000 global businesses working towards improving their benchmarks and raising standards across all industries.

Sustainability continues to be a key area of focus for Owen Mumford, demonstrated through commitments towards emissions reduction targets with the SBTi. The company has set a target to reach a 50% reduction in carbon emissions by 2030 and become net zero by 2045. Owen Mumford has also joined the Race to Zero movement in 2021, a collaboration of leading companies across the globe supporting efforts to achieve zero carbon recovery.

The report charts the organization’s progress against its chosen United Nations Sustainable Development Goals (SDGs), covering a variety of well-being, infrastructural, and responsible consumption themes. Highlights for 2021 include continued support for the promotion of women in STEM subjects through local collaboration with schools and colleges, to continued evaluation of its logistics output to reduce carbon emissions and lead times to customers. Other initiatives support the company’s commitment to its associates, customers, products, and the planet.

“This past year has been challenging for us all as we entered the second year of the pandemic. Thankfully, 2021 marked a year of growth, action and above all else, resilience for Owen Mumford. Whether achieving B Corp certification, committing to reducing our emissions footprint, or continuing investment in more sustainable products, we have a great deal to be proud of,” said Jarl Severn, CEO of Owen Mumford.

He concluded, “Our goal is to continue with a positive influence on the medical device industry, leading by example on how products should be responsibly made, companies should be ethically run, and futures should be protected. I hope that the hard work and commitment from everyone at Owen Mumford encourages other companies and individuals to implement their own action plans and work towards a better future for everyone.”

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.